Differentiation of reinfection from relapse in recurrent Lyme disease
- PMID: 23150958
- PMCID: PMC3526003
- DOI: 10.1056/NEJMoa1114362
Differentiation of reinfection from relapse in recurrent Lyme disease
Abstract
Background: Erythema migrans is the most common manifestation of Lyme disease. Recurrences are not uncommon, and although they are usually attributed to reinfection rather than relapse of the original infection, this remains somewhat controversial. We used molecular typing of Borrelia burgdorferi isolates obtained from patients with culture-confirmed episodes of erythema migrans to distinguish between relapse and reinfection.
Methods: We determined the genotype of the gene encoding outer-surface protein C (ospC) of B. burgdorferi strains detected in cultures of skin or blood specimens obtained from patients with consecutive episodes of erythema migrans. After polymerase-chain-reaction amplification, ospC genotyping was performed by means of reverse line-blot analysis or DNA sequencing of the nearly full-length gene. Most strains were further analyzed by determining the genotype according to the 16S-23S ribosomal RNA intergenic spacer type, multilocus sequence typing, or both. Patients received standard courses of antibiotics for erythema migrans.
Results: B. burgdorferi isolates obtained from 17 patients who received a diagnosis of erythema migrans between 1991 and 2011 and who had 22 paired episodes of this lesion (initial and second episodes) were available for testing. The ospC genotype was found to be different at each initial and second episode. Apparently identical genotypes were identified on more than one occasion in only one patient, at the first and third episodes, 5 years apart, but different genotypes were identified at the second and fourth episodes.
Conclusions: None of the 22 paired consecutive episodes of erythema migrans were associated with the same strain of B. burgdorferi on culture. Our data show that repeat episodes of erythema migrans in appropriately treated patients were due to reinfection and not relapse. (Funded by the National Institutes of Health and the William and Sylvia Silberstein Foundation.).
Figures
Comment in
-
Reinfection versus relapse in Lyme disease.N Engl J Med. 2012 Nov 15;367(20):1950-1. doi: 10.1056/NEJMe1211361. N Engl J Med. 2012. PMID: 23150963 No abstract available.
-
Reinfection versus relapse in Lyme disease.N Engl J Med. 2013 Mar 14;368(11):1063-4. doi: 10.1056/NEJMc1215615. N Engl J Med. 2013. PMID: 23484837 No abstract available.
-
Reinfection versus relapse in Lyme disease.N Engl J Med. 2013 Mar 14;368(11):1063. doi: 10.1056/NEJMc1215615. N Engl J Med. 2013. PMID: 23484838 No abstract available.
Similar articles
-
Analysis of Borrelia burgdorferi genotypes in patients with Lyme arthritis: High frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritis.Arthritis Rheum. 2009 Jul;60(7):2174-82. doi: 10.1002/art.24812. Arthritis Rheum. 2009. PMID: 19565522 Free PMC article.
-
Borrelia burgdorferi genetic markers and disseminated disease in patients with early Lyme disease.J Clin Microbiol. 2006 Dec;44(12):4407-13. doi: 10.1128/JCM.01077-06. Epub 2006 Oct 11. J Clin Microbiol. 2006. PMID: 17035489 Free PMC article.
-
Genotyping of Borrelia from formalin-fixed paraffin-embedded skin biopsies of cutaneous borreliosis and tick bite reactions by assays targeting the intergenic spacer region, ospA and ospC genes.Br J Dermatol. 2014 Sep;171(3):528-43. doi: 10.1111/bjd.12855. Epub 2014 Aug 27. Br J Dermatol. 2014. PMID: 24471698
-
Molecular diversity of the ospC gene in Borrelia. Impact on phylogeny, epidemiology and pathology.Wien Klin Wochenschr. 2002 Jul 31;114(13-14):562-7. Wien Klin Wochenschr. 2002. PMID: 12422602 Review.
-
Alternatives to Serologic Testing for Diagnosis of Lyme Disease.Clin Lab Med. 2015 Dec;35(4):815-25. doi: 10.1016/j.cll.2015.07.005. Epub 2015 Aug 31. Clin Lab Med. 2015. PMID: 26593259 Review.
Cited by
-
Characterization and genomic analysis of the Lyme disease spirochete bacteriophage ϕBB-1.PLoS Pathog. 2024 Apr 1;20(4):e1012122. doi: 10.1371/journal.ppat.1012122. eCollection 2024 Apr. PLoS Pathog. 2024. PMID: 38558079 Free PMC article.
-
Suppression of host humoral immunity by Borrelia burgdorferi varies over the course of infection.Infect Immun. 2024 Apr 9;92(4):e0001824. doi: 10.1128/iai.00018-24. Epub 2024 Mar 22. Infect Immun. 2024. PMID: 38514468 Free PMC article.
-
What Influence Could the Acceptance of Visitors Cause on the Epidemic Dynamics of a Reinfectious Disease?: A Mathematical Model.Acta Biotheor. 2024 Feb 25;72(1):3. doi: 10.1007/s10441-024-09478-w. Acta Biotheor. 2024. PMID: 38402514 Free PMC article.
-
Characterization and genomic analysis of the Lyme disease spirochete bacteriophage ϕBB-1.bioRxiv [Preprint]. 2024 Jan 13:2024.01.08.574763. doi: 10.1101/2024.01.08.574763. bioRxiv. 2024. Update in: PLoS Pathog. 2024 Apr 1;20(4):e1012122. doi: 10.1371/journal.ppat.1012122. PMID: 38260690 Free PMC article. Updated. Preprint.
-
Circulating antibody-secreting cells are a biomarker for early diagnosis in patients with Lyme disease.PLoS One. 2023 Nov 3;18(11):e0293203. doi: 10.1371/journal.pone.0293203. eCollection 2023. PLoS One. 2023. PMID: 37922270 Free PMC article.
References
-
- Dandache P, Nadelman RB. Erythema migrans. Infect Dis Clin North Am. 2008;22:235–60. - PubMed
-
- Steere AC, Bartenhagen NH, Craft JE, et al. The early clinical manifestations of Lyme disease. Ann Intern Med. 1983;99:76–82. - PubMed
-
- Nowakowski J, McKenna D, Nadelman RB, et al. Failure of treatment with cephalexin for Lyme disease. Arch Fam Med. 2000;9:563–7. - PubMed
-
- Nowakowski J, Nadelman RB, Sell R, et al. Long-term follow-up of patients with culture-confirmed Lyme disease. Am J Med. 2003;115:91–6. - PubMed
-
- Krause PJ, Foley DT, Burke GS, Christianson D, Closter L, Spielman A. Reinfection and relapse in early Lyme disease. Am J Trop Med Hyg. 2006;75:1090–4. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical